C.F.R. homeSearch C.F.R.
C.F.R.Title 21Chapter I—Food and Drug Administration, Department of Health and Human ServicesSubchapter H—Medical DevicesPart 884—Obstetrical and Gynecological DevicesSubpart F—Obstetrical and Gynecological Therapeutic Devices

21 C.F.R. § 884.5980 (2026)

Surgical mesh for transvaginal pelvic organ prolapse repair

Edition and currency
eCFR text as of Sept. 29, 2026. The text is the edition Syfert holds; for a past event, check the version in force on that date.
Other sources
CURRENTeCFR text as of Sept. 29, 2026 ACTIVE · 5 IN 5Y cited 2020–2023 7citing cases
At a glance

Courts have cited this section in 7 opinions since 2020, 5 of them in the last five years.

(a) Identification. Surgical mesh for transvaginal pelvic organ prolapse repair is a prescription device intended to reinforce soft tissue in the pelvic floor. This device is a porous implant that is made of synthetic material, non-synthetic material, or a combination of synthetic and non-synthetic materials. This device does not include surgical mesh for other intended uses (§ 878.3300 of this chapter).

(b) Classification. Class III (premarket approval).

(c) Date premarket application approval or notice of completion of a product development protocol is required. A premarket application approval or notice of completion of a product development protocol for a device is required to be filed with the Food and Drug Administration on or before July 5, 2018, for any surgical mesh described in paragraph (a) of this section that was in commercial distribution before May 28, 1976, or that has, on or before July 5, 2018, been found substantially equivalent to a surgical mesh described in paragraph (a) of this section that was in commercial distribution before May 28, 1976. Any other surgical mesh for transvaginal pelvic organ prolapse repair shall have an approved premarket application or declared completed product development protocol in effect before being placed in commercial distribution.

[81 FR 361, Jan. 5, 2016, as amended at 81 FR 369, Jan. 5, 2016]
The 7 cases that cite 21 C.F.R. § 884.5980 most heavily, weighted by court and treatment. RelevanceNewestTreatment
1
GREENBarbara Kaiser v. Johnson & Johnson, 947 F.3d 996 (7th Cir. 2020).
cites § 884.5980 1×cited by 78 cases
Where it cites § 884.5980
“See 21 C.F.R. § 884.5980 . D. Kaiser’s Surgery and Lawsuit Kaiser suffered from a severe anterior pelvic-organ pro- lapse.”
The case’s holding
A medical device manufacturer discharges its duty to warn under the learned-intermediary doctrine by providing adequate warnings to physicians.
Later courts cite it for
“under indiana's learned-intermediary doctrine, a medical-device manufacturer can discharge the duty to warn by providing adequate warnings to physicians.” · 8 citing courts
2
GREENElizabeth Hrymoc Vs. Ethicon, Inc. Mary Mcginnis Vs. C.R. Bard, Inc., 249 A.3d 191 (N.J. Super. Ct. App. Div. 2021).
cites § 884.5980 2×cited by 0 cases
Where it cites § 884.5980
“5, 2016) (the "Reclassification Action Summary") (summarizing the history of surgical mesh and transvaginal mesh classifications) (codified at 21 C.F.R. § 884.5980 (2016)). A-5151-17 23 manufacturers to identify and describe the device, state its intended use, specify all…”
3
GREENElizabeth Hrymoc Vs. Ethicon, Inc. Mary Mcginnis Vs. C.R. Bard, Inc., 249 A.3d 191 (N.J. Super. Ct. App. Div. 2021).
cites § 884.5980 2×cited by 0 casesunpublished
Where it cites § 884.5980
“5, 2016) (the "Reclassification Action Summary") (summarizing the history of surgical mesh and transvaginal mesh classifications) (codified at 21 C.F.R. § 884.5980 (2016)). A-5151-17 64 manufacturers to identify and describe the device, state its intended use, specify all…”
Later courts cite it for
“imposes strict liability if a product manufacturer or seller has failed to provide adequate warnings concerning the dangers posed by a product's use.” · 2 citing courts
4
GREENElizabeth Hrymoc Vs. Ethicon, Inc. Mary Mcginnis Vs. C.R. Bard, Inc., 249 A.3d 191 (N.J. Super. Ct. App. Div. 2021).
cites § 884.5980 2×cited by 0 cases
Where it cites § 884.5980
“5, 2016) (the "Reclassification Action Summary") (summarizing the history of surgical mesh and transvaginal mesh classifications) (codified at 21 C.F.R. § 884.5980 (2016)). A-5151-17 23 manufacturers to identify and describe the device, state its intended use, specify all…”
5
GREENBarbara Kaiser v. Johnson & Johnson, No. 18-2944 (7th Cir. Jan. 14, 2020).
cites § 884.5980 1×cited by 0 cases
Where it cites § 884.5980
“See 21 C.F.R. § 884.5980 . D. Kaiser’s Surgery and Lawsuit Kaiser suffered from a severe anterior pelvic-organ pro- lapse.”
6
GREENElizabeth Hrymoc v. Ethicon, Inc., 297 A.3d 1245 (N.J. 2023).
cites § 884.5980 1×cited by 0 cases
Where it cites § 884.5980
“21 C.F.R. § 884.5980 . 7 The predicate device for the Avaulta Solo was the “Avaulta Support System,” which was cleared in 2007.”
Later courts cite it for
“an appellate court reviews a trial court's evidentiary rulings, like those at issue here, with substantial deference and will not overturn such a ruling unless it constituted a clear abuse of discretion.” · 4 citing courts
7
NO FLAGBergman v. Johnson & Johnson, No. 0:20-cv-02693 (D. Minn. Oct. 29, 2021).
cites § 884.5980 1×cited by 0 casesunknown
Where it cites § 884.5980
“Budnik has been discontinued and was categorized by the Food and Drug Administration as a Class III medical device, regulated under 21 C.F.R. § 884.5980 , while the two products used on Ms.”

The flag is Syfertize’s treatment of the citing case itself, not of the statute. “Where it cites” is the passage in the opinion; the holding is a summary of the whole case and may concern another point. Annotations are extracted automatically from the opinions in the Syfert caselaw corpus.

Citing cases by year
202020212023

One bar per year. Tallest: 4 cases in 2021. These are opinions in the Syfert collection, which holds more of some courts’ recent opinions than their older ones, so a rise can reflect what the collection holds and not more litigation.

By court
N.J. Super. Ct. App. Div.37th Cir.2D. Minn.1N.J.1
By subsection

Courts have not cited this section by subsection, so its cases are not split up here. The Leading cases tab lists the cases that cite it most heavily.

Enactment and amendments

Syfert holds no separate history line for this section. Where this code prints a source or history note, it appears with the text, usually at the end.

Versions

Edition shown: eCFR text as of Sept. 29, 2026. Syfert holds no earlier or later version of this section.

C.F.R. Home  |  Search C.F.R.  |  Search cases for this section  |  syfert.com